Stocks
GlaxoSmithKline (GSK) ROE US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 46.4% | 36.9% | 29.0% | 18.8% | 35.0% | 24.8% | ||
| Changes by years, y/y, % | -95pp | -10pp | -8pp | -10pp | +16pp | -2.4% | |||
GlaxoSmithKline. ROE, %
GlaxoSmithKline. ROE, changes, pp
GlaxoSmithKline (GSK) ROE US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| ROE, % | ? | 17.3% | 16.9% | 25.3% | 35.0% | 24.8% | 24.8% | |
| Changes by years, y/y, % | -15pp | -11pp | +7pp | +16pp | +8pp | |||
| Changes by quarters, q/q, % | -2pp | 0pp | +8pp | +10pp | -10pp | |||
